8-K
filed June 30, 2023, 7:59 PM ET
ticker VNRX
CIK 0000093314
other material
confidence high
sentiment neutral
materiality 0.40
VolitionRx stockholders approve 1.95M share increase in 2015 Stock Incentive Plan
VOLITIONRX LTD
- Stockholders voted to amend the 2015 Stock Incentive Plan, increasing available shares by 1,950,000 to 9,700,000.
- All eight director nominees elected: Barnes, Colman, Faulkes, Futcher, Henshall, Innes, Nguyen, Reynolds.
- Ratification of auditor Sadler, Gibb & Associates passed with 41.8M for vs 631K against.
- Advisory vote on executive compensation approved (16.7M for, 13.5M against).
- Annual meeting initially adjourned on June 23 due to lack of quorum; reconvened June 28 with quorum.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VOLITIONRX LTD shareholders approved Non-binding advisory vote on the compensation of the Company's named executive officers at the 2023-06-28 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
Proposal 3 : The stockholders approved, by a non-binding advisory vote, the compensation of the Company’s named executive officers as described in the Proxy Statement. The voting results are as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 16,678,808 13,455,552 452,358 11,936,520
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VOLITIONRX LTD shareholders approved Election of eight members to the Board of Directors to hold office until the 2024 annual meeting at the 2023-06-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
Proposal 1 : The stockholders elected eight members to the Board of Directors to hold office until the 2024 annual meeting of stockholders and until their successors are duly elected and qualified, or until their earlier resignation or removal. The voting results are as follows: Nominee Votes For Votes Withheld Broker Non-Votes Dr. Phillip Barnes 17,190,976 13,395,742 11,936,520 Dr. Alan Colman 16,686,555 13,900,163 11,936,520 Dr. Martin Faulkes 17,893,663 12,693,055 11,936,520 Dr. Edward Futcher 16,702,277 13,884,441 11,936,520 Mickie Henshall 17,613,328 12,973,390 11,936,520 Guy Innes 16,601,593 13,985,125 11,936,520 Kim Nguyen 17,435,938 13,150,780 11,936,520 Cameron Reynolds 17,854,848 12,731,870 11,936,520
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VOLITIONRX LTD shareholders approved Amendment to the 2018 Equity Incentive Plan (inferred from context) at the 2023-06-28 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
Proposal 4 : The Company’s stockholders approved the amendment to the Plan. The voting results are as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 16,541,886 13,692,776 352,056 11,936,520
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VOLITIONRX LTD shareholders approved Ratification of the selection of Sadler, Gibb & Associates, LLC as the Company's independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
Proposal 2 : The stockholders ratified the selection of Sadler, Gibb & Associates, LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2023. The voting results are as follows: Votes For Votes Against Votes Abstained 41,847,066 631,190 44,982
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.